首页|复方扶芳藤合剂调节免疫抑制小鼠外周血CD19+B细胞CD69和PD-1的表达

复方扶芳藤合剂调节免疫抑制小鼠外周血CD19+B细胞CD69和PD-1的表达

扫码查看
为评估复方扶芳藤合剂(compound fufangteng mixture,CFM)对环磷酰胺诱导的免疫抑制BALB/c小鼠B细胞的免疫增强作用,将BALB/c小鼠随机分为空白对照(normal control,NC)组、模型(model control,MC)组、CFM低剂量(low-dose CFM,LD)组、CFM 中剂量(medium-dose CFM,MD)组、CFM 高剂量组(high-dose CFM,HD)组和阳性对照(positive con-trol,PC)组.采用FACS检测小鼠外周血和脾脏CD19+B细胞表面活化分子(CD69、CD38)和耗竭分子(PD-1、CD95)的表达.结果显示,与NC组比较,MC组外周血CD19+B细胞百分比显著下降(P<0.05),LD组、MD组、HD组外周血CD19+B细胞百分比有改善的趋势,并随着CFM剂量的递增而升高;LD组、MD组外周血CD19+B细胞CD69和PD-1表达水平显著高于NC组(P<0.05);与外周血CD19+B细胞比较,脾脏中CD19+B细胞CD69、CD38、PD-1和CD95的表达水平在各组间差异无统计学意义(P>0.05).该研究提示,CFM对小鼠外周血CD19+B细胞可能具有改善作用,且对其CD69和PD-1有调节作用.
Compound fufangteng mixture regulates CD69 and PD-1 expressions of peripheral CD19+B cells in immunosuppressed mice
This study aims to evaluate the immune-enhancing effect of compound fufangteng mixture(CFM)on B cells in cyclo-phosphamide-induced immunosuppression in BALB/c mice.BALB/c mice were randomly divided into normal control(NC)group,model control(MC)group,low-dose CFM(LD)group,medium-dose CFM(MD)group,high-dose CFM(HD)group,and positive control(PD)group.The expressions of CD19+B cell surface activating molecules(CD69,CD38)and exhaustion molecules(PD-1,CD95)in mice peripheral blood and spleen were detected by FACS.The results showed that compared to that of the NC group,the percentage of CD19+B cells in the peripheral blood of MC group decreased significantly(P<0.05),while the percentages of CD19+B cells in the peripheral blood of LD group,MD group,and HD group increased in a CFM dose-dependent manner.The expressions of CD69 and PD-1 of CD19+B cells in the peripheral blood of LD group and MD group were significantly higher than those of the NC group(P<0.05).There was no significant difference in the expression levels of CD69,CD38,PD-1,and CD95 of splenetic CD19+B cells among the six groups(P>0.05).Altogether,the results suggest that the CFM may improve the percentage of peripheral blood CD19+B cells and regulate CD69 and PD-1 in immuno-suppression mice.

compound fufangteng mixtureimmunosuppressionCD19+B cellCD69programmed death 1

彭丽珊、陈果、李建明、杨洋、刘显、肖健

展开 >

广西中医药大学 广西高发传染病中西医结合转化医学重点实验室,南宁 530001

湖北省中医院 脾胃病科,武汉 430060

复方扶芳藤合剂 免疫抑制 CD19+B细胞 CD69 程序性死亡受体1

国家自然科学基金广西自然科学基金面上项目广西壮族自治区中医药管理局基金项目

818607802020GXNSFAA297162GXZYA20220087

2024

现代免疫学
上海市免疫学研究所,上海市免疫学会

现代免疫学

CSTPCD
影响因子:0.4
ISSN:1001-2478
年,卷(期):2024.44(5)
  • 12